Epidemiology of infectious encephalitis, differences between a prospective study and hospital discharge data

Epidemiology and Infection

Volumn 141, Issue 11, 2013, Pages 2256-2268

  Bernard, S ^a   Mailles, A ^b   Stahl, J P ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b French Institute for Public Health Surveillance   (France)

Author keywords

Encephalitis; epidemiology; herpes simplex virus (HSV)

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CAUSAL ATTRIBUTION; CENTRAL NERVOUS SYSTEM TUBERCULOSIS; CONTROLLED STUDY; DATA ANALYSIS; DISEASE SURVEILLANCE; ENCEPHALITIS; EPIDEMIC; FATALITY; FEMALE; FRANCE; HERPES SIMPLEX ENCEPHALITIS; HERPES ZOSTER ENCEPHALITIS; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; INFECTION RATE; INFORMATION RETRIEVAL; LISTERIOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROSPECTIVE STUDY; TREND STUDY;

ADOLESCENT; ADULT; AGED; BACTERIAL INFECTIONS; ENCEPHALITIS; FEMALE; FRANCE; HOSPITALS; HUMANS; MALE; MIDDLE AGED; VIRUS DISEASES; YOUNG ADULT;

EID: 84885070220     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268812002518     Document Type: Article

References (39)

1. Mailles A, Stahl JP. Infectious encephalitis in France in 2007: a national prospective study. Clinical Infectious Diseases 2009; 49: 1838-1847.
2. Granerod J, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicenter, population-based prospective study. Lancet Infectious Diseases 2010; 10: 835-844.
3. Glaser CA, et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clinical Infectious Diseases 2006; 43: 1565-1577.
4. Khetsuriani N, Holman RC, Anderson LJ. Burden of encephalitis-associated hospitalisations in the United States, 1988-1997. Clinical Infectious Diseases 2002; 35: 175-182.
5. Davison KL, et al. Viral encephalitis in England, 1989-1998: what did we miss? Emerging Infectious Diseases 2003; 9: 234-240.
6. Trevejo RT. Acute encephalitis hospitalisations, California, 1990-1999: unrecognized arboviral encephalitis? Emerging Infectious Diseases 2004; 10: 1442-1449.
7. Mailles A, Vaillant V, Stahl JP. Infectious encephalitis in France from 2000 to 2002: the hospital database is a valuable but limited source of information for epidemiological studies. Médecine et Maladies Infectieuses 2007; 37: 95-102.
8. Huppatz C, et al. Etiology of encephalitis in Australia, 1990-2007. Emerging Infectious Diseases 2009; 15: 1359-1365.
9. Barbadoro P, et al. Trend of hospital utilization for encephalitis. Epidemiology and Infection 2012; 140: 753-764.
10. Johnson RT. Acute encephalitis. Clinical Infectious Diseases 1996; 23: 219-224.
11. Tunkel AR, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clinical Infectious Diseases 2008; 47: 303-327.
12. Dalmau J, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurology 2008; 7: 1091-1098.
13. Irani SR, et al. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly nonparaneoplastic disorder of both sexes. Brain 2010; 133: 1655-1667.
14. Stahl JP, et al. Epidemiology of viral encephalitis in 2011. Médecine et Maladies Infectieuses 2011; 41: 453-464.
15. Granerod J, et al. Causality in acute encephalitis: defining etiologies. Epidemiology and Infection 2010; 138: 783-800.
16. Whitley RJ, Lakeman F. Herpes simplex virus infections of the central nervous system: therapeutic and diagnostic considerations. Clinical Infectious Diseases 1995; 20: 414-420.
17. Glaser CA, et al. In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998-2000. Clinical Infectious Diseases 2003; 36: 731-742.
18. Campbell GL, et al. West Nile virus. Lancet Infectious Diseases 2002; 2: 519-529.
19. Chua KB, et al. Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet 1999; 354: 1257-1259.
20. Ooi MH, et al. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurology 2010; 9: 1097-1105.
21. Domenech C, et al. Role of Mycoplasma pneumoniae in pediatric encephalitis. European Journal of Clinical Microbiology and Infectious Diseases 2009; 28: 91-94.
22. Kunze U. Tick-borne encephalitis: the impact of epidemiology, changing lifestyle, and environmental factors. Conference report of the 12th Annual Meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE). Vaccine 2011; 29: 1355-1356.
23. Haddow AD, Bixler D, Odoi A. The spatial epidemiology and clinical features of reported cases of La Crosse virus infection in West Virginia from 2003 to 2007. BMC Infectious Diseases 2011; 11: 29.
24. Clarke M, et al. Childhood encephalopathy: viruses, immune response, and outcome. Developmental Medicine and Child Neurology 2006; 48: 294-300.
25. Hokkanen L, Launes J. Neuropsychological sequelae of acute-onset sporadic viral encephalitis. Neuropsychological Rehabilitation 2007; 17: 450-477.
26. Bode AV, et al. West Nile virus disease: a descriptive study of 228 patients hospitalised in a 4-county region of Colorado in 2003. Clinical Infectious Diseases 2006; 42: 1234-1240.
27. Murgue B, et al. West Nile outbreak in horses in southern France, 2000: the return after 35 years. Emerging Infectious Diseases 2001; 7: 692-696.
28. Hansmann Y, et al. Tick-borne encephalitis in eastern France. Scandinavian Journal of Infectious Diseases 2006; 38: 520-526.
29. Zeller HG, Schuffenecker I. West Nile virus: an overview of its spread in Europe and the Mediterranean basin in contrast to its spread in the Americas. European Journal of Clinical Microbiology and Infectious Diseases 2004; 23: 147-156.
30. Sirbu A, et al. Outbreak of West Nile virus infection in humans, Romania, July to October 2010. Eurosurveillance 2011; 16.
31. Rizzo C, et al. West Nile virus transmission with human cases in Italy, August-September 2009. Eurosurveillance 2009; 14.
32. Papa A, et al. Ongoing outbreak of West Nile virus infections in humans in Greece, July-August 2010. Eurosurveillance 2010; 15.
33. Institut de Veille Sanitaire. Human surveillance of West Nile virus and Toscana virus infections (http://www.invs.sante.fr/Regions-et-territoires/L- InVS-dansvotre-region/Provence-Alpes-Cote-d-Azur-et-Corse/Programmes-de-la-Cire/ Surveillance-humaine-des-Infections-a-virus-West-Nile-et-Toscana). Accessed 24 May 2011.
34. Reuter D, Schneider-Schlaulies J. Measles virus infection of the CNS: Human disease, animal models, and approaches to therapy. Medical Microbiology and Immunology 2010; 199: 261-271.
35. Measles Surveillance in France. (http://www.invs. sante.fr/fr/Dossiers- thematiques/Maladies-infectieuses/Maladies-a-prevention-vaccinale/Rougeole/ Points-dactualites). Accessed 16 March 2012.
36. Habek M, et al. Unusual cause of dementia in an immunocompetent host: toxoplasmic encephalitis. Neurological Sciences 2009; 30: 45-49.
37. Kaushik RM, et al. Toxoplasmic meningoencephalitis in an immunocompetent host. Transactions of the Royal Society of Tropical Medicine and Hygiene 2005; 99: 874-878.
38. Brouqui P, et al. Meningitis due to lymphocytic choriomeningitis virus: four cases in France. Clinical Infectious Diseases 1995; 20: 1082-1083.
39. Fender P, Weill A. Epidemiology, public health and medical rates databases. Revue d'Epidémiologie et de Santé Publique 2004; 52: 113-117.